(Q82452802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Bladder cancer: meta-analysis of BCG versus mitomycin C--a deeper insight? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

1 reference

Andreas Böhle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

8-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20062070%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.253

16 January 2020

exact match

0 references

cites work

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study wit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.253

Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20062070

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20062070